amoxicillin

Overview

Amoxicillin is a widely used β-lactam antibiotic in the penicillin class. It acts by inhibiting bacterial cell-wall synthesis through binding to penicillin-binding proteins, thereby impairing peptidoglycan cross-linking and leading to bacterial growth inhibition and cell death in susceptible organisms. Clinically, it is used for a range of bacterial infections, and its role in therapy is often considered alongside related agents such as amoxicillin-clavulanate, cefiderocol, and ceftazidime-avibactam when resistance patterns or infection severity influence antibiotic selection.

Beyond its established antimicrobial use, amoxicillin has also been studied as a biologically active exposure in developmental and environmental contexts. Recent work has examined its effects on dental enamel formation, where it was considered alongside fluoride, calcium, and vitamin D in a rat incisor model. Other studies have used amoxicillin as a model compound in analytical chemistry and environmental monitoring, reflecting its relevance as both a pharmaceutical and a contaminant of interest.

Recent Publications Summary

Recent clinical trials have evaluated amoxicillin in combination therapies for bacterial infections. In the treatment of Helicobacter pylori infection, a 14-day dual therapy regimen of amoxicillin combined with either keverprazan or esomeprazole was assessed in a prospective, multicenter randomized controlled trial; keverprazan-amoxicillin achieved eradication rates of 87.9% to 93.5% depending on analysis type, compared to 80.3% to 88.3% for esomeprazole-amoxicillin, with non-inferiority confirmed 42572417Aug. Amoxicillin and amoxicillin-clavulanate remain first-line treatment options recommended by clinical guidelines for acute otitis media in children, with prescribing rates of approximately 80% documented across pediatric hospital populations 42036512Apr. For acute sinusitis in adults, clinical practice has not yet established consensus regarding whether amoxicillin or amoxicillin-clavulanate should be preferred as initial therapy 41999289Apr.

Pharmacokinetic studies have investigated amoxicillin's tissue penetration in complex infections. In patients with infected diabetic foot ulcers, the achievement of adequate tissue and serum concentrations of amoxicillin-clavulanate was compared across bolus and continuous administration strategies to optimize bactericidal activity and therapeutic outcomes 42218112May.

Developmental toxicology studies have documented unintended effects of amoxicillin exposure. Combined exposure to fluoride and amoxicillin was associated with impaired enamel formation in animal models, resulting in disorganization of enamel prisms and increased apoptotic activity in ameloblasts; vitamin D and calcium supplementation were investigated as potential protective factors against these enamel alterations 42184017May.

Emerging analytical applications have employed amoxicillin as a model compound for pharmaceutical detection. Using graphene-based electrochemical sensors, amoxicillin was detected in water at sub-ppb sensitivity levels, demonstrating the applicability of hydrogen peroxide-assisted redox mediation coupled with chronoamperometric detection for quantifying pharmaceutical contaminants in aquatic systems 42060697Apr.

What Changes, What Holds

1. Keverprazan establishes a novel dual-therapy role for amoxicillin in H. pylori eradication
NEW DIRECTION Keverprazan is a previously untested combination partner for amoxicillin not discussed in the Overview 42572417Aug, achieving competitive H. pylori eradication rates. First-line status for acute otitis media stands established, whereas acute sinusitis therapy remains without consensus guidance.

2. Amoxicillin-clavulanate efficacy in diabetic foot ulcers depends critically on infusion strategy
NEW DIRECTION Bolus and continuous infusion routes achieve distinct tissue and serum concentration profiles 42218112May, establishing a previously unspecified pharmacokinetic optimization parameter for complex wound infection. The Overview's general discussion of amoxicillin-clavulanate use does not address this specific indication or the optimization dimension this work reveals.

3. Combined fluoride-amoxicillin exposure damages developing enamel through specific cellular mechanisms
NEW DIRECTION Enamel prism disorganization and enhanced ameloblast apoptosis are now documented mechanisms of harm in co-exposure models 42184017May. The Overview notes only that amoxicillin affects enamel and is studied in developmental contexts, without characterizing the nature or mechanisms of those effects.

4. Graphene electrochemical sensing achieves sub-ppb detection of amoxicillin in environmental samples
METHOD Graphene-based electrodes with hydrogen peroxide-assisted chronoamperometric detection attain picomolar-scale sensitivity for pharmaceutical residue quantification 42060697Apr. The Overview already identifies amoxicillin's role in environmental monitoring applications; this work advances the analytical measurement platform and detection sensitivity available for that purpose.

Overview update candidates: H. pylori eradication with keverprazan-amoxicillin; amoxicillin-clavulanate tissue penetration optimization in diabetic foot ulcers; fluoride-amoxicillin co-exposure harm mechanisms.